{"id":"NCT01987895","sponsor":"Actelion","briefTitle":"Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea","officialTitle":"A Multi-center, Randomized, Double-blind Study to Compare the Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-03-27","primaryCompletion":"2017-02-26","completion":"2017-03-24","firstPosted":"2013-11-20","resultsPosted":"2018-05-04","lastUpdate":"2025-02-04"},"enrollment":632,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Clostridium Difficile Infection"],"interventions":[{"type":"DRUG","name":"Cadazolid","otherNames":["ACT-179811"]},{"type":"DRUG","name":"Vancomycin","otherNames":["Vancocin"]},{"type":"DRUG","name":"Cadazolid-matching placebo","otherNames":[]},{"type":"DRUG","name":"Vancomycin-matching placebo","otherNames":[]}],"arms":[{"label":"Cadazolid","type":"EXPERIMENTAL"},{"label":"Vancomycin","type":"ACTIVE_COMPARATOR"}],"summary":"This clinical study is conducted to assess the efficacy of cadazolid compared to vancomycin in subjects with Clostridium difficile-associated diarrhea (CDAD).","primaryOutcome":{"measure":"Clinical Cure Rate (CCR) in the Modified Intent-to-treat Population","timeFrame":"Up to Day 12 on average (end-of-treatment + 2 days)","effectByArm":[{"arm":"Cadazolid","deltaMin":83.8,"sd":null},{"arm":"Vancomycin","deltaMin":85.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["30709665","29680101"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":19,"n":304},"commonTop":["Headache","Abdominal pain","Nausea"]}}